EYEN Market Cap History



Below is a table of the EYEN market cap history going back to 1/25/2018:

Date EYEN Market Cap
1/25/201898.57M
3/27/201891.42M
5/4/201884.46M
8/10/201855.39M
11/8/201840.36M
3/20/201966.59M
5/9/201970.31M
8/8/201955.58M
8/5/2019928.35M
11/8/201948.91M
3/25/202046.28M
5/8/202072.78M
8/13/202095.49M
11/10/202085.35M
3/29/2021130.94M
5/12/2021119.97M
8/10/2021111.32M
11/10/2021111.32M
3/30/202298.58M
5/13/202273.52M
11/10/202264.28M
3/28/2023122.33M
4/27/2023189.96M
5/10/2023164.55M
8/8/202378.72M
11/9/202353.61M
3/15/202475.34M

Also see: EYEN Shares Outstanding History
and EYEN YTD Return
EYEN Historical Market Cap:
-4.28% CAGR
EYEN Historical Market Cap: +-4.28% CAGR

Mouse over chart for data details
1/25/2018 ...3/15/2024
Eyenovia is a pre-commercial ophthalmic technology company developing the Optejet® delivery system for use both in combination with its own drug-device therapeutic programs as well as out-licensing for additional indications. Co.'s drug-device therapeutic programs include MicroPine, MicroLine and Mydcombi™. MicroPine is Co.'s topical therapy for the treatment of progressive myopia, a back-of-the-eye ocular disease associated with pathologic axial elongation and sclero-retinal stretching. MicroLine is Co.'s investigational pharmacologic treatment for presbyopia. Mydcombi™ is Co.'s fixed combination formulation of tropicamide-phenylephrine for mydriasis. We show 27 historical shares outstanding datapoints in our EYEN shares outstanding history coverage, used to compute EYEN market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing EYEN market cap history over the course of time is important for investors interested in comparing EYEN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of EYEN versus a peer is one thing; comparing EYEN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like EYEN can fluctuate over the course of history. With this page we aim to empower investors researching EYEN by allowing them to research the EYEN market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree EYEN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Eyenovia (EYEN) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

EYES Market Cap History
EYPT Market Cap History
FATE Market Cap History
FBIO Market Cap History
FBRX Market Cap History
FCRE Market Cap History
FCSC Market Cap History
FDMT Market Cap History
FEMY Market Cap History
FGEN Market Cap History
More Healthcare companies »

 

EYEN Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.